Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment-Reference-Cited by-同舟云学术

Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment

Published:2019-12-05 Issue:3 Volume:125 Page:369-378
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Blazevski Alexandar¹²³^ORCID,Scheltema Matthijs J.¹²⁴^ORCID,Amin Amer¹²^ORCID,Thompson James E.¹²³^ORCID,Lawrentschuk Nathan⁵⁶⁷^ORCID,Stricker Phillip D.¹²³^ORCID

Affiliation:

1. St. Vincent's Prostate Cancer Centre; Darlinghurst New South Wales Australia

2. Garvan Institute of Medical Research; Kinghorn Cancer Centre; Darlinghurst New South Wales Australia

3. St. Vincent's Clinical School; University of New South Wales; Sydney New South Wales Australia

4. Department of Urology; Amsterdam UMC; Amsterdam The Netherlands

5. EJ Whitten Prostate Cancer Research Centre at Epworth Healthcare; Melbourne Victoria Australia

6. Division of Cancer Surgery; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

7. Department of Surgery; Olivia Newton-John Cancer Centre; Austin Hospital; University of Melbourne; Melbourne Victoria Australia

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14951/fullpdf

Reference50 articles.

1. New and established technology in focal ablation of the prostate: a systematic review;Valerio;Eur Urol,2017

2. Death by electric currents and by lighting. The Goulstonian lectures for 1913;Jex-Blake;Br Med J,1913

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal therapy for prostate cancer;Abdominal Radiology;2024-08-20

2. Advantages of pulsed electric field ablation for COPD: Excellent killing effect on goblet cells;Bioelectrochemistry;2024-08

3. Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE);BMC Urology;2024-07-25

4. Focal Therapy in Grade Group 3 Prostate Cancer;Current Urology Reports;2024-07-02

5. A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial;Cancers;2024-06-08